Neuroscience nanotechnology: Progress, opportunities and challenges

Nature Reviews Neuroscience

Volumn 7, Issue 1, 2006, Pages 65-74

  Silva, Gabriel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN; FREE RADICAL; MACROGOL; MRZ 2 576; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NANOPARTICLE; NEUROPEPTIDE; OLIGONUCLEOTIDE; POLY(BUTYLCYANOACRYLATE); POLYETHYLENEIMINE; POLYMER; POLYSORBATE 80; QUANTUM DOT; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CELL INTERACTION; CLINICAL MEDICINE; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EXCITOTOXICITY; GLIA CELL; HUMAN; MEDICAL RESEARCH; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NANOTECHNOLOGY; NERVE CELL; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROSCIENCE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOMEDICAL ENGINEERING; HUMANS; MODELS, NEUROLOGICAL; NANOTECHNOLOGY; NEURONS; NEUROSCIENCES;

EID: 29244472857     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn1827     Document Type: Review

References (100)

1. Liu, D., Park, S. H., Reif, J. H. & LaBean, T. H. DNA nanotubes self-assembled from triple-crossover tiles as templates for conductive nanowires. Proc. Natl Acad. Sci. USA 101, 717-722 (2004).
2. Cui, Y., Wei, Q., Park, H. & Lieber, C. M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289-1292 (2001).
3. Silva, G. A. Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. Surg. Neurol. 63, 301-306 (2005).
4. Silva, G. A. Small neuroscience: the nanostructure of the central nervous system and emerging nanotechnology applications. Curr. Nanosci. 3, 225-236 (2005).
5. Ai, H. et al. Biocompatibility of layer-by-layer self-assembled nanofilm on silicone rubber for neurons. J. Neurosci. Methods 128, 1-8 (2003).
6. Fan, Y. W. et al. Culture of neural cells on silicon wafers with nano-scale surface topograph. J. Neurosci. Methods 120, 17-23 (2002).
7. Kim, D. H., Abidian, M. & Martin, D. C. Conducting polymers grown in hydrogel scaffolds coated on neural prosthetic devices. J. Biomed. Mater. Res. A 71, 577-585 (2004).
8. Mohammed, J. S., DeCoster, M. A. & McShane, M. J. Micropatterning of nanoengineered surfaces to study neuronal cell attachment in vitro. Biomacromolecules 5, 1745-1755 (2004).
9. Kramer, S. et al. Preparation of protein gradients through the controlled deposition of protein-nanoparticle conjugates onto functionalized surfaces. J. Am. Chem. Soc. 126, 5388-5395 (2004).
10. Moxon, K. A. et al. Nanostructured surface modification of ceramic-based microelectrodes to enhance biocompatibility for a direct brain-machine interface. IEEE Trans. Biomed. Eng. 51, 881-889 (2004). A good example of electrode modification using nanoengineered materials to improve neuronal adhesion while limiting the effects of contaminating cells to improve the functionality of the electrodes.
11. Shenai, M. B. et al. A novel MEA/AFM platform for measurement of real-time, nanometric morphological alterations of electrically stimulated neuroblastoma cells. IEEE Trans. Nanobioscience 3, 111-117 (2004).
12. Vu, T. Q. et al. Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment. Biomaterials 26, 1895-1903 (2005). An excellent example of a nanoengineered cell-signalling platform technology designed to selectively and controllably stimulate target neurons by immobilizing neurotransmitter molecules on a surface.
13. Saifuddin, U. et al. Assembly and characterization of biofunctional neurotransmitter-immobilized surfaces for interaction with postsynaptic membrane receptors. J. Biomed. Mater. Res. A 66, 184-191 (2003).
14. Levene, M. J., Dombeck, D. A., Kasischke, K. A., Molloy, R. P. & Webb, W. W. In vivo multiphoton microscopy of deep brain tissue. J. Neurophysiol. 91, 1908-1912 (2004).
15. Dahan, M. et al. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302, 442-445 (2003). First major work showing the application of functionalized quantum dots to target neurons in the investigation of a specific neurophysiological process. The authors took advantage of the physical properties of quantum dots to achieve single-particle tracking of glycine receptors.
16. Howarth, M., Takao, K., Hayashi, Y. & Ting, A. Y. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc. Natl Acad. Sci. USA 102, 7583-7588 (2005).
17. Fan, H. et al. Surfactant-assisted synthesis of water-soluble and biocompatible semiconductor quantum dot micelles. Nano. Lett. 5, 645-648 (2005).
18. Vu, T. Q. et al. Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano. Lett. 5, 603-607 (2005).
19. Pathak, S., Cao, E., Davidson, M., Jin, S.-H. & Silva, G. A. Quantum dot applications in neuroscience: new tools for probing neurons and glia. J. Neurosci. (in the press).
20. Yang, F. et al. Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials 25, 1891-1900 (2004).
21. Silva, G. A. et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303, 1352-1355 (2004). First major work describing the application of a nanoengineered material designed specifically for neural regeneration that had multiple, functional properties, including in vitro self-assembly under physiological conditions and preferential differentiation of neurons over astrocytes.
22. Dugan, L. L. et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 7, 243-246 (2001).
23. Dugan, L. L., Gabrielsen, J. K., Yu, S. P., Lin, T. S. & Choi, D. W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3, 129-135 (1996).
24. Dugan, L. L. et al. Carboxyfullerenesas neuroprotective agents. Proc. Natl Acad. Sci. USA 94, 9434-9439 (1997).
25. 60, fullerenols, as glutamate receptor antagonists and neuroprotective agents. J. Neurosci. Res. 62, 600-607 (2000).
26. Dugan, L. L. et al. Fullerene-based antioxidants and neurodegenerative disorders. 7, 243-246 (2001). A good example of the application of fullerene-derived nanoparticles intended to protect the CNS from free radical toxicity following injury. This and related research have shown promising initial results in vivo.
27. Lockman, P. R., Mumper, R. J., Khan, M. A. & Allen, D. D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28, 1-13 (2002). Reviews current strategies for delivering drugs and other small molecules across the BBB.
28. Vinogradov, S. V., Batrakova, E. V. & Kabanov, A. V. Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 15, 50-60 (2004).
29. Koziara, J. M., Lockman, P. R., Allen, D. D. & Mumper, R. J. In situ blood-brain barrier transport of nanoparticles. Pharm. Res. 20, 1772-1778 (2003).
30. Olbrich, C., Gessner, A., Kayser, O. & Muller, R. H. Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J. Drug Target. 10, 387-396 (2002).
31. Schroeder, U., Sommerfeld, P., Ulrich, S. & Sabel, B. A. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J. Pharm. Sci. 87, 1305-1307 (1998).
32. Kreuter, J. et al. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 20, 409-416 (2003).
33. Kreuter, J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 47, 65-81 (2001).
34. Alyaudtin, R. N. et al. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J. Drug Target. 9, 209-221 (2001).
35. Brigger, I. et al. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther. 303, 928-936 (2002).
36. Garcia-Garcia, E. et al. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. Cell. Mol. Life Sci. 62, 1400-1408 (2005).
37. Gelperina, S. E. et al. Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol. Lett. 126, 131-141 (2002). Describes a practical example of the delivery of the anticancer drug doxorubicin across the BBB in vivo and illustrates the significant potential these technologies have for drug delivery to the CNS.
38. Kreuter, J. et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 10, 317-325 (2002).
39. Park, T. H. & Shuler, M. L. Integration of cell culture and microfabrication technology. Biotechnol. Prog. 19, 243-253 (2003).
40. Oliva, A. A. Jr, James, C. D., Kingman, C. E., Craighead, H. G. & Banker, G. A. Patterning axonal guidance molecules using a novel strategy for microcontact printing. Neurochem. Res. 28, 1639-1648 (2003).
41. Andersson, H. & van den Berg, A. Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab. Chip 4, 98-103 (2004).
42. Branch, D. W., Wheeler, B. C., Brewer, G. J. & Leckband, D. E. Long-term maintenance of patterns of hippocampal pyramidal cells on substrates of polyethylene glycol and microstamped polylysine. IEEE Trans. Biomed. Eng. 47, 290-300 (2000). An excellent example of classical microscale-patterning approaches for controlling the growth and connections of patterned neurons.
43. Wheeler, B. C., Corey, J. M., Brewer, G. J. & Branch, D. W. Microcontact printing for precise control of nerve cell growth in culture. J. Biomech. Eng. 121, 73-78 (1999).
44. Chang, J. C., Brewer, G. J. & Wheeler, B. C. Modulation of neural network activity by patterning. Biosens. Bioelectron. 16, 527-533 (2001).
45. Hansma, H. G., Kasuya, K. & Oroudjev, E. Atomic force microscopy imaging and pulling of nucleic acids. Curr. Opin. Struct. Biol. 14, 380-385 (2004).
46. Santos, N. C. & Castanho, M. A. An overview of the biophysical applications of atomic force microscopy. Biophys. Chem. 107, 133-149 (2004).
47. West, J. L. & Halas, N. J. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annu. Rev. Biomed. Eng. 5, 285-292 (2003).
48. Murphy, C. J. Optical sensing with quantum dots. Anal. Chem. 74, 520A-526A (2002).
49. Chan, W. C. & Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016-2018 (1998).
50. Vanmaekelbergh, D. & Liljeroth, P. Electron-conducting quantum dot solids: novel materials based on colloidal semiconductor nanocrystals. Chem. Soc. Rev. 34, 299-312 (2005).
51. Saxton, M. J. & Jacobson, K. Single-particle tracking: applications to membrane dynamics. Annu. Rev. Biophys. Biomol. Struct. 26, 373-399 (1997).
52. Bonneau, S., Cohen, L. D. & Dahan, M. A multiple target approach for single quantum dot tracking. IEEE Int. Symp. Biomed Imaging, Arlington, Virginia, USA, 15-18 April, 664-667 (2004).
53. Bonneau, S., Dahan, M. & Cohen, L. D. Single quantum dot tracking based on perceptual grouping using minimal paths in a spatiotemporal volume. IEEE Trans. Image Process. 14, 1384-1395 (2005).
54. Arya, H. et al. Quantum dots in bio-imaging: revolution by the small. Biochem. Biophys. Res. Commun. 329, 1173-1177 (2005).
55. Mansson, A. et al. In vitro sliding of actin filaments labelled with single quantum dots. Biochem. Biophys. Res. Commun. 314, 529-534 (2004).
56. Lidke, D. S. et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nature Biotechnol. 22, 198-203 (2004).
57. Jaiswal, J. K., Goldman, E. R., Mattoussi, H. & Simon, S. M. Use of quantum dots for live cell imaging. Nature Methods 1, 73-78 (2004).
58. Wu, X. et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nature Biotechnol. 21, 41-46 (2003).
59. Watson, A., Wu, X. & Bruchez, M. Lighting up cells with quantum dots. Biotechniques 34, 296-300, 302-303 (2003).
60. Tokumasu, F. & Dvorak, J. Development and application of quantum dots for immunocytochemistry of human erythrocytes. J. Microsc. 211, 256-261 (2003).
61. Ness, J. M., Akhtar, R. S., Latham, C. B. & Roth, K. A. Combined tyramide signal amplification and quantum dots for sensitive and photostable immunofluorescence detection. J. Histochem. Cytochem. 51, 981 -987 (2003).
62. Jaiswal, J. K., Mattoussi, H., Mauro, J. M. & Simon, S. M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nature Biotechnol. 21, 47-51 (2003).
63. Gao, X. & Nie, S. Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol. 21, 371-373 (2003).
64. Chan, W. C. et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13, 40-46 (2002).
65. Akerman, M. E., Chan, W. C., Laakkonen, P., Bhatia, S. N. & Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl Acad. Sci. USA 99, 12617-12621 (2002).
66. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005).
67. Braydich-Stolle, L., Hussain, S., Schlager, J. & Hofmann, M. C. In vitro cytotoxicity of nanoparticles in mammalian germ-line stem cells. Toxicol. Sci. 88, 412-419 (2005).
68. Lovric, J. et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 83, 377-385 (2005).
69. Voura, E. B., Jaiswal, J. K., Mattoussi, H. & Simon, S. M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nature Med. 10, 993-998 (2004).
70. Stang, F., Fansa, H., Wolf, G. & Keilhoff, G. Collagen nerve conduits - assessment of biocompatibility and axonal regeneration. Biomed. Mater. Eng. 15, 3-12 (2005).
71. Gamez, E. et al. Photofabricated gelatin-based nerve conduits: nerve tissue regeneration potentials. Cell Transplant. 13, 549-564 (2004).
72. Ma, W. et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp. Neurol. 190, 276-288 (2004).
73. Park, K. I., Teng, Y. D. & Snyder, E. Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nature Biotechnol. 20, 1111-1117 (2002).
74. Balgude, A. P., Yu, X., Szymanski, A. & Bellamkonda, R. V. Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials 22, 1077-1084 (2001).
75. Dillon, G. P., Yu, X., Sridharan, A., Ranieri, J. P. & Bellamkonda, R. V. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J. Biomater. Sci. Polym. Ed. 9, 1049-1069 (1998).
76. Katayama, Y. et al. Coil-reinforced hydrogel tubes promote nerve regeneration equivalent to that of nerve autografts. Biomaterials 27, 505-518 (2006).
77. Tsai, E. C., Dalton, P. D., Shoichet, M. S. & Tator, C. H. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 27, 519-533 (2006).
78. Levesque, S. G., Lim, R. M. & Shoichet, M. S. Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. Biomaterials 26, 7436-7446 (2005).
79. Yu, T. T. & Shoichet, M. S. Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials 26, 1507-1514 (2005).
80. Tashiro, K. et al. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J. Biol. Chem. 264, 16174-16182 (1989).
81. Nomizu, M. et al. Structure-activity study of a laminin α1 chain active peptide segment Ile-Lys-Val-Ala-Val (IKVAV). FEBS Lett. 365, 227-231 (1995).
82. Powell, S. K. et al. Neural cell response to multiple novel sites on laminin-1. J. Neurosci. Res. 61, 302-312 (2000).
83. Tunggal, P., Smyth, N., Paulsson, M. & Ott, M. C. Laminins: structure and genetic regulation. Microsc. Res. Tech. 51, 214-227 (2000).
84. Blass, J. P. Cerebrometabolic abnormalities in Alzheimer's disease. Neurol. Res. 25, 556-566 (2003).
85. Gagliardi, R. J. Neuroprotection, excitotoxicity and NMDA antagonists. Arq. Neuropsiquiatr. 58, 583-588 (2000).
86. Lo, E. H., Dalkara, T. & Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nature Rev. Neurosci. 4, 399-415 (2003).
87. Mahadik, S. P. & Mukherjee, S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res. 19, 1-17 (1996).
88. Mishra, O. P. & Delivoria-Papadopoulos, M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res. Bull. 48, 233-238 (1999).
89. Gust, D., Moore, T. A. & Moore, A. L. Photochemistry of supramolecular systems containing C60. J. Photochem. Photobiol. B 58, 63-71 (2000).
90. Zhang, J., Albelda, M. T., Liu, Y. & Canary, J. W. Chiral nanotechnology. Chirality 17, 404-420 (2005).
91. Fortina, P., Kricka, L. J., Surrey, S. & Grodzinski, P. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol. 23, 168-173 (2005).
92. Scott, L. T. Methods for the chemical synthesis of fullerenes. Angew. Chem. Int. Ed. Engl. 43, 4994-5007 (2004).
93. Segura, J. L. & Martin, N. New concepts in tetrathiafulvalene chemistry. Angew. Chem. Int. Ed. Engl. 40, 1372-1409 (2001).
94. Cheng, Y. S., Champliaud, M. F., Burgeson, R. E., Marinkovich, M. P. & Yurchenco, P. D. Self-assembly of laminin isoforms. J. Biol. Chem. 272, 31525-31532 (1997).
95. Hohenester, E. & Engel, J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 21, 115-128 (2002).
96. Giles, J. Size matters when it comes to safety, report warns. Nature 430, 599 (2004).
97. Giles, J. Nanotechnology: what is there to fear from something so small? Nature 426, 750 (2003).
98. Oberdorster, G., Oberdorster, E. & Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839 (2005).
99. Hartgerink, J. D., Beniash, E. & Stupp, S. I. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc. Natl Acad. Sci. USA 99, 5133-5138 (2002).
100. Hartgerink, J. D., Beniash, E. & Stupp, S. I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294, 1684-1688 (2001).